Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Research indicates that female risk of developing Alzheimer’s disease (AD) is greater than that of males. Moderate reduction of calorie intake, known as calorie restriction (CR), reduces pathology in AD mouse models, and is a potentially translatable prevention measure for individuals at-risk for AD, as well as an important tool for understanding how the brain endogenously attenuates age-related pathology. Whether sex influences the response to CR remains unknown. In this study, we assessed the effect of CR on beta-amyloid peptide (Aβ) pathology and hippocampal CA1 neuron specific gene expression in the Tg2576 mouse model of cerebral amyloidosis. Relative to ad libitum (AL) feeding, CR feeding significantly reduced hippocampal Aβ burden in 15 month old female, but not age-matched male, Tg2576 mice. Sustained CR also significantly reduced expression of presenilin enhancer 2 (Psenen) and presenilin 1 (Ps1), components of the γ-secretase complex, in Tg2576 females. These results indicate that long-term CR significantly reduces age-dependent female Tg2576 Aβ pathology, which is likely to involve CR-mediated reductions in γ-secretase-dependent amyloid precursor protein (APP) metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 2×
“…2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and other types of cellular injury that ultimately drive neuropathology associated with AD (Goedert and Spillantini, 2006; Götz et al., 2009; Hardy and Allsop, 1991; Hyman et al., 1984; von Gunten et al., 2006).”
BackgroundCaloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
The Effect of Retarded Growth Upon the Length of Life Span and Upon the Ultimate Body Size
McCay, C. M., Crowell, M. F., & Maynard, L. A. (1935) · The Journal of Nutrition · doi:10.1093/jn/10.1.63 · Cited by 2,264
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · cited 1×
“…which exhibits age-dependent increases in Aβ plaque load and concomitant memory deficits driven by overexpression of a human APP variant (APPswe) responsible for early-onset AD (Callahan et al., 2001; Citron et al., 1992; Good and Hale, 2007; Hsiao et al., 1996; Mullan et al., 1992).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 4×
“…from sequential processing of the APP holoprotein, induces synaptic dysfunction (Almeida et al., 2005; Hsieh et al., 2006; Jacobsen et al., 2006; Snyder et al., 2005), oxidative damage (Bartley et al., 2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and…”
InfluentialMullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513 · cited 2×
“We employed the Tg2576 mouse model of APP overexpression, which exhibits age-dependent increases in Aβ plaque load and concomitant memory deficits driven by overexpression of a human APP variant (APPswe) responsible for early-onset AD (Callahan et al., 2001; Citron et al., 1992; Good and Hale, 2007; Hsiao et al., 1996…”
BackgroundMethodThe efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317 · cited 2×
“035 for EC (Gundersen et al., 1999), and was well below biological variability.”
BackgroundInfluentialImpact of caloric restriction on health and survival in rhesus monkeys from the NIA study
Mattison, J. A., Roth, G. S., Beasley, T. M., Tilmont, E. M., Handy, A. M., Herbert, R. L., Longo, D. L., Allison, D. B., Young, J. E., Bryant, M., et al. (2012) · Nature · doi:10.1038/nature11432 · Cited by 1,145 · cited 2×
“, 2005), in addition to extending healthspan and lifespan in many species (Colman et al., 2009; Hart et al., 1999; Kealy et al., 2002; Klass, 1977; Mattison et al., 2012; McCay et al., 1935; Roe et al., 1995; Rous, 1914).”
BackgroundAMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701 · cited 4×
“Alzheimer’s disease (AD) is a high-prevalence neurodegenerative disorder characterized by progressive loss of memory and executive function resulting from synaptic dysfunction and neurodegeneration within vulnerable brain regions (Almeida et al., 2005; Hsieh et al., 2006; Jacobsen et al., 2006; Snyder et al., 2005).”
BackgroundInfluentialQin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., Zhao, W., Thiyagarajan, M., MacGrogan, D., Rodgers, J. T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602909200 · Cited by 626 · cited 2×
“Increased A disintegrin and metalloproteinase domain (Adam)dependent α-secretase function through activation of sirtuin 1 (Sirt1), a protein deacetylase that is stimulated by CR, has been previously implicated as a potential mechanism underlying CR-dependent Aβ reductions (Qin et al., 2006).”
BackgroundNeuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502 · cited 1×
“Anatomical delineation of hippocampal CA1 included all layers with borders as previously described (Calhoun et al., 1998), and borders for the entire EC with perirhinal cortex, parasubiculum and other neighboring regions were determined based upon detailed cytoarchitectonic differentiation.”
MethodSelf-citationFan, Y., Batmanghelich, N., Clark, C. M., & Davatzikos, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.031 · Cited by 477 · cited 1×
“AD pathology exhibits a spatial and temporal occurrence in which specific neuron types in defined brain regions display pathology, while leaving other cell types and areas relatively spared (de LaCoste and White, 1993; Fan et al., 2008).”
BackgroundViña, J., & Lloret, A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100501 · Cited by 447
Yang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429
Self-citationCorrelation and Large-Scale Simultaneous Significance Testing
Efron, B. (2007) · Journal of the American Statistical Association · doi:10.1198/016214506000001211 · Cited by 405
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397
Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379 · cited 1×
“…2006; Jacobsen et al., 2006; Snyder et al., 2005), oxidative damage (Bartley et al., 2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and other types of cellular injury that ultimately drive neuropathology associated with AD (Goedert and Spillantini, 2006; Götz…”
BackgroundCaloric restriction attenuates Aβ-deposition in Alzheimer transgenic models
Patel, N. V., Gordon, M. N., Connor, K. E., Good, R. A., Engelman, R. W., Mason, J., Morgan, D. G., Morgan, T. E., & Finch, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.014 · Cited by 329
Mouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316
Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · cited 3×
“…et al., 2008; Lee et al., 2002; Thies et al., 2013, Vina and Lloret, 2010; Wang et al., 2003) and that pronounced female pathology may be associated with metabolic or nutritional status (Azad et al.,2007; Gustafson et al., 2003; Hayden and Zandi, 2006; Wolf et al., 2012; Yue et al., 2005).”
BackgroundHigh-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Émond, V., Julien, P., & Calon, F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.022 · Cited by 288
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model
Hirata-Fukae, C., Li, H.-F., Hoe, H.-S., Gray, A. J., Minami, S. S., Hamada, K., Niikura, T., Hua, F., Tsukagoshi-Nagai, H., Horikoshi-Sakuraba, Y., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.079 · Cited by 284
Augmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice
Callahan, M. J., Lipinski, W. J., Bian, F., Durham, R. A., Pack, A., & Walker, L. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64064-3 · Cited by 274
Saura, C. A., Chen, G., Malkani, S., Choi, S.-Y., Takahashi, R. H., Zhang, D., Gouras, G. K., Kirkwood, A., Morris, R. G. M., & Shen, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1247-05.2005 · Cited by 157
Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo
Chabrier, M. A., Blurton-Jones, M., Agazaryan, A. A., Nerhus, J. L., Martinez-Coria, H., & LaFerla, F. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0172-12.2012 · Cited by 123
Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease
GUNTEN, A., KOVARI, E., BUSSIERE, T., RIVARA, C., GOLD, G., BOURAS, C., HOF, P., & GIANNAKOPOULOS, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.008 · Cited by 101 · cited 1×
“…2012; Wan et al., 2011), tau aggregation (Chabrier et al., 2012; Oddo et al., 2006), and other types of cellular injury that ultimately drive neuropathology associated with AD (Goedert and Spillantini, 2006; Götz et al., 2009; Hardy and Allsop, 1991; Hyman et al., 1984; von Gunten et al., 2006).”
BackgroundGinsberg, S. D., Elarova, I., Ruben, M., Tan, F., Counts, S. E., Eberwine, J. H., Trojanowski, J. Q., Hemby, S. E., Mufson, E. J., & Che, S. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023593.77052.f7 · Cited by 97 · cited 1×
“…region that have demonstrated expression signatures of homogeneous cell type populations are more sensitive detectors of neuronal gene expression changes than regional dissections that contain an admixture of cellular populations (Ginsberg et al., 2000, 2004, 2010, 2012; Ginsberg and Che, 2005).”
BackgroundSelf-citationChoi, J. H. K., Berger, J. D., Mazzella, M. J., Morales‐Corraliza, J., Cataldo, A. M., Nixon, R. A., Ginsberg, S. D., Levy, E., & Mathews, P. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06277.x · Cited by 83 · cited 2×
“Signals were quantified using ImageJ software (NIH, Bethesda, MD). β-tubulin (β-Tub) immunoreactivity signal was used as a loading control (Choi et al., 2009; Mathews et al., 2002; Morales-Corraliza et al., 2009).”
MethodSelf-citation
Research works printed but not linked: 60
- Alldred, 2008, Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain, Int. J. Mol. Sci., 9, 2091, 10.3390/ijms9112091 · DOI · Paper page
- Alldred, 2009, Terminal continuation (TC) RNA amplification without second strand synthesis, J. Neurosci. Methods, 177, 381, 10.1016/j.jneumeth.2008.10.027 · DOI · Paper page
- Alldred, 2012, Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction, Neurobiol. Dis., 45, 751, 10.1016/j.nbd.2011.10.022 · DOI · Paper page
- Alldred, 2014, Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD), Brain Struct. Funct.
- Azad, 2007, Gender differences in dementia risk factors, Gend. Med., 4, 120, 10.1016/S1550-8579(07)80026-X · DOI · Paper page
- Balducci, 2011, The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice, J. Alzheimers. Dis., 24, 799, 10.3233/JAD-2011-101839 · DOI
- Bartley, 2012, Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade, J. Alzheimers. Dis., 28, 855, 10.3233/JAD-2011-111172 · DOI
- Calhoun, 1998, Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice, Neurobiol Aging, 19, 599, 10.1016/S0197-4580(98)00098-0 · DOI · Paper page
- Chow, 2010, An overview of APP processing enzymes and products, Neuromolecular Med., 12, 1, 10.1007/s12017-009-8104-z · DOI · Paper page
- Crump, 2013, Development and mechanism of γ-secretase modulators for Alzheimer's disease, Biochemistry, 52, 3197, 10.1021/bi400377p · DOI · Paper page
- De LaCoste, 1993, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging, 14, 1, 10.1016/0197-4580(93)90015-4 · DOI · Paper page
- Dewachter, 2002, Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice, J. Neurosci., 22, 3445, 10.1523/JNEUROSCI.22-09-03445.2002 · DOI · Paper page
- Ding, 2013, Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's, PLoS One, 8, e59825, 10.1371/journal.pone.0059825 · DOI · Paper page
- Esler, 2000, Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1, Nat. Cell Biol., 2, 428, 10.1038/35017062 · DOI · Paper page
- Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI · Paper page
- Ginsberg, 2005, RNA amplification strategies for small sample populations, Methods, 37, 229, 10.1016/j.ymeth.2005.09.003 · DOI
- Ginsberg, 2008, Transcriptional profiling of small samples in the central nervous system, Methols Mol. Biol., 439, 147, 10.1007/978-1-59745-188-8_10 · DOI · Paper page
- Ginsberg, 2012, Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease, Neurobiol. Dis., 45, 99, 10.1016/j.nbd.2011.07.013 · DOI · Paper page
- Ginsberg, 2010, Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression, Biol. Psychiatry, 68, 885, 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
- Ginsberg, 2005, Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons, J. Comp. Neurol., 487, 107, 10.1002/cne.20535 · DOI · Paper page
- Ginsberg, 2006, Down regulation of Trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease, J. Neurochem., 97, 475, 10.1111/j.1471-4159.2006.03764.x · DOI · Paper page
- Ginsberg, 2000, Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons, Ann. Neurol., 48, 77, 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A · DOI · Paper page
- Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
- Golde, 2013, γ-Secretase inhibitors and modulators, Biochim. Biophys. Acta, 1828, 2898, 10.1016/j.bbamem.2013.06.005 · DOI · Paper page
- Good, 2007, The “Swedish” mutation of the amyloid precursor protein (APPswe) dissociates components of object-location memory in aged Tg2576 mice, Behav. Neurosci., 121, 1180, 10.1037/0735-7044.121.6.1180 · DOI · Paper page
- Götz, 2009, Alzheimer's disease selective vulnerability and modeling in transgenic mice, J. Alzheimers. Dis., 18, 243, 10.3233/JAD-2009-1143 · DOI · Paper page
- Goutte, 2002, APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos, Proc. Natl. Acad. Sci. U. S. A., 99, 775, 10.1073/pnas.022523499 · DOI · Paper page
- Gundersen, 1988, The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use, APMIS, 96, 857, 10.1111/j.1699-0463.1988.tb00954.x · DOI · Paper page
- Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch. Intern. Med., 163, 1524, 10.1001/archinte.163.13.1524 · DOI · Paper page
- Hart, 1999, Adaptive role of caloric intake on the degenerative disease processes, Toxicol. Sci., 52, 3, 10.1093/toxsci/52.2.3 · DOI
- Hemby, 2003, Neuron-specific age-related decreases in dopamine receptor subtype mRNAs, J. Comp. Neurol., 456, 176, 10.1002/cne.10525 · DOI · Paper page
- Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 7, 10.1126/science.274.5284.99 · DOI · Paper page
- Irizarry, 2001, beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging, Am. J. Pathol., 158, 173, 10.1016/S0002-9440(10)63955-7 · DOI
- Kacharmina, 1999, Preparation of cDNA from single cells and subcellular regions, Methods Enzymol., 303, 3, 10.1016/S0076-6879(99)03003-7 · DOI · Paper page
- Kealy, 2002, Effects of diet restriction on life span and age-related changes in dogs, J. Am. Vet. Med. Assoc., 220, 1315, 10.2460/javma.2002.220.1315 · DOI · Paper page
- Klass, 1977, Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span, Mech. Ageing Dev., 6, 413, 10.1016/0047-6374(77)90043-4 · DOI · Paper page
- Kunzler, 2014, APOE modulates the effect of estrogen therapy on Aβ accumulation, Neurosci. Lett., 560, 131, 10.1016/j.neulet.2013.12.032 · DOI · Paper page
- Lee, 1987, Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats, J. Neurosci., 7, 3474, 10.1523/JNEUROSCI.07-11-03474.1987 · DOI · Paper page
- Lee, 2002, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 99, 7705, 10.1073/pnas.092034699 · DOI · Paper page
- Li, 2003, Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003 · DOI · Paper page
- Marlow, 2003, APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity, Biochem. Biophys. Res. Commun., 305, 502, 10.1016/S0006-291X(03)00797-6 · DOI
- Mathews, 2002, Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments, J. Biol. Chem., 277, 36415, 10.1074/jbc.M205208200 · DOI · Paper page
- Mikulca, 2014, Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches, J. Clin. Pharm. Ther., 39, 25, 10.1111/jcpt.12112 · DOI · Paper page
- Morales-Corraliza, 2009, In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice, PLoS One, 4, e7134, 10.1371/journal.pone.0007134 · DOI · Paper page
- Morrison, 2002, Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease, Prog. Brain Res., 136, 467, 10.1016/S0079-6123(02)36039-4 · DOI · Paper page
- Mouton, 2009, Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice, Neurosci. Lett., 464, 184, 10.1016/j.neulet.2009.08.038 · DOI · Paper page
- Pedrini, 2009, Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology, Mol. Neurodegener., 4, 40, 10.1186/1750-1326-4-40 · DOI · Paper page
- Placanica, 2009, Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease, PLoS One, 4, e5088, 10.1371/journal.pone.0005088 · DOI · Paper page
- Rajendran, 2012, Membrane trafficking pathways in Alzheimer's disease, Traffic, 13, 759, 10.1111/j.1600-0854.2012.01332.x · DOI · Paper page
- Roe, 1995, The Biosure Study: influence of composition of diet and food consumption on longevity, degenerative diseases and neoplasia in Wistar rats studied for up to 30 months post weaning, Food Chem. Toxicol., 33, 1S, 10.1016/0278-6915(94)00139-F · DOI
- Rous, 1914, The influence of diet on transplanted and spontaneous mouse tumors, J. Exp. Med., 20, 433, 10.1084/jem.20.5.433 · DOI · Paper page
- Schmidt, 2012, Abeta measurement by enzyme-linked immunosorbent assay, Methods Mol. Biol., 849, 507, 10.1007/978-1-61779-551-0_34 · DOI · Paper page
- Shiraishi, 2004, PEN-2 enhances gamma-cleavage after presenilin heterodimer formation, J. Neurochem., 90, 1402, 10.1111/j.1471-4159.2004.02597.x · DOI
- Sivilia, 2013, Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice, BMC Neurosci., 14, 1, 10.1186/1471-2202-14-44 · DOI
- Steiner, 2002, PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin, J. Biol. Chem., 277, 39062, 10.1074/jbc.C200469200 · DOI · Paper page
- Wan, 2011, β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease, Free Radic. Biol. Med., 50, 122, 10.1016/j.freeradbiomed.2010.10.707 · DOI
- Wang, 2005, Caloric restriction attenuates ß-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB J., 18, 1, 10.1096/fj.04-2370com · DOI · Paper page
- Wolf, 2012, Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention, J. Alzheimers. Dis., 32, 217, 10.3233/JAD-2012-120478 · DOI
- Yue, 2005, Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model, Proc. Natl. Acad. Sci. U. S. A., 102, 19198, 10.1073/pnas.0505203102 · DOI · Paper page
- Zhang, 2000, Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1, Nat. Cell Biol., 2, 463, 10.1038/35017108 · DOI · Paper page
Cited by
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870
The effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches
Mary, A., Eysert, F., Checler, F., & Chami, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01631-6 · Cited by 244
Effect of nutrition on neurodegenerative diseases. A systematic review
Bianchi, V. E., Herrera, P. F., & Laura, R. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1681088 · Cited by 249
Neurogenesis in aging and age-related neurodegenerative diseases
Culig, L., Chu, X., & Bohr, V. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101636 · Cited by 218
Metadata
- Authors
- Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 36
- Issue
- 3
- Pages
- 1293-1302
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2101531721
- Cited by
- 97
- References
- 35
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH (GM007238, RR029893, AG043375, AG014449, AG017617, HD057564)
- Alzheimer's Association (IIRG-12–237253)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.